論文

査読有り 国際誌
2020年3月

A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management

ANNALS OF THE AMERICAN THORACIC SOCIETY
  • Kimihiko Murase
  • Kiminobu Tanizawa
  • Takuma Minami
  • Takeshi Matsumoto
  • Ryo Tachikawa
  • Naomi Takahashi
  • Toru Tsuda
  • Yoshiro Toyama
  • Motoharu Ohi
  • Toshiki Akahoshi
  • Yasuhiro Tomita
  • Koji Narui
  • Hiroshi Nakamura
  • Tetsuro Ohdaira
  • Hiroyuki Yoshimine
  • Tomomasa Tsuboi
  • Yoshihiro Yamashiro
  • Shinichi Ando
  • Takatoshi Kasai
  • Hideo Kita
  • Koichiro Tatsumi
  • Naoto Burioka
  • Keisuke Tomii
  • Yasuhiro Kondoh
  • Hirofumi Takeyama
  • Tomohiro Handa
  • Satoshi Hamada
  • Toru Oga
  • Takeo Nakayama
  • Tetsuo Sakamaki
  • Satoshi Morita
  • Tomohiro Kuroda
  • Toyohiro Hirai
  • Kazuo Chin
  • 全て表示

17
3
開始ページ
329
終了ページ
337
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1513/AnnalsATS.201907-494OC
出版者・発行元
AMER THORACIC SOC

Rationale: The effects of telemedicine on adherence in patients with obstructive sleep apnea with long-term continuous positive airway pressure (CPAP) use have never been investigated.Objectives: To examine effects of a telemedicine intervention on adherence in long-term CPAP users.Methods: In a prospective, randomized, multicenter noninferiority trial conducted in 17 sleep centers across Japan, patients who had used CPAP for >3 months and were receiving face-to-face follow-up by physicians every 1 or 2 months were randomized by a coordinating center in a blind manner to the following three groups: 1) follow-up every 3 months accompanied by a monthly telemedicine intervention (telemedicine group: TM-group), 2) follow-up every 3 months (3-month group: 3M-group), or 3) monthly follow-up (1-month group: 1M-group). Each group was followed up for 6 months. The change in percentage of days with >= 4 h/night of CPAP use from baseline to the end of the study period was evaluated. A decline of >= 5% from baseline was considered deterioration of adherence. Noninferiority of TM- and 3M-groups compared with the 1M-group according to the number of patients with deterioration of adherence was evaluated with the Farrington and Manning test (noninferiority margin 15%).Results: A total of 483 patients were analyzed (median duration of CPAP use, 29 [interquartile range, 12-71] mo), and deterioration of adherence was found in 41 of 161 (25.5%), 55 of 166 (33.1%), and 35 of 156 (22.4%) patients in the TM-, 3M-, and 1M-groups, respectively. The noninferiority of the TM-group compared with the 1M-group was verified (difference in percentage of patients with adherence deterioration, 3.0%; 95% confidence interval [CI], -4.8% to 10.9%; P < 0.01). Conversely, the 3M-group did not show noninferiority to the 1M-group (percentage difference, 10.7%; 95% CI, 2.6% to 18.8%; P = 0.19). In the stratified analysis, adherence in TM- and 1M-group patients with poor adherence at baseline improved (TM: 45.8% +/- 18.2% to 57.3% +/- 24.4%; P < 0.01; 1M: 43.1% +/- 18.5% to 53.6% 24.3%; P < 0.01), whereas that of the 3M-group did not (39.3% +/- 20.8% to 39.8% +/- 24.8%; P =0.84).Conclusions: Intensive telemedicine support could help to optimize CPAP adherence even after long-term CPAP use.

リンク情報
DOI
https://doi.org/10.1513/AnnalsATS.201907-494OC
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31689141
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000518194300015&DestApp=WOS_CPL
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079492786&origin=inward
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85079492786&origin=inward
ID情報
  • DOI : 10.1513/AnnalsATS.201907-494OC
  • ISSN : 1546-3222
  • eISSN : 2325-6621
  • PubMed ID : 31689141
  • SCOPUS ID : 85079492786
  • Web of Science ID : WOS:000518194300015

エクスポート
BibTeX RIS